Preservative for in-vitro diagnostic reagent and application thereof
By using a combination of diethyl acetaminomalonate, dilauryl glycerol sulfate, and diethyltriaminepentaacetic acid as a preservative, the problems of preservative toxicity and environmental pollution in in vitro diagnostic reagents have been solved, thereby improving the stability and measurement precision of the reagents.
Patent Information
- Application Number
- CN202411095000.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-12
- Publication Date
- 2024-11-22
AI Technical Summary
Preservatives in existing in vitro diagnostic reagents are toxic, leading to reduced activity of tool enzymes, affecting measurement precision, and traditional preservatives are harmful to the environment.
A combination of diethyl acetaminomalonate, dilauryl glycerol sulfate, and diethyltriaminepentaacetic acid was used as a preservative to inhibit microbial growth through synergistic effects, avoid inhibition of tool enzymes, and improve reagent stability.
It provides a virtually non-toxic preservative that effectively inhibits bacterial growth, improves reagent stability, does not affect the activity of tool enzymes, and is environmentally friendly.
Smart Images

Figure BDA0004987663920000031 
Figure BDA0004987663920000041 
Figure BDA0004987663920000042
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of in vitro diagnostic reagents, and in particular relates to a preservative for in vitro diagnostic reagents and application thereof. Background Art
[0002] In the field of medical diagnosis, the key materials of biochemical and immunological test kits contain biogenic substances such as antibodies, antigens, cells, and enzymes, and proteins, glucose, BSA, etc. are added to their components. These substances originally play a role in nutrition and protection of the biogenic substances in the key materials, but at the same time they also provide a suitable environment for the growth of microorganisms. As the number of microorganisms grows exponentially every day, it will not only affect the appearance of in vitro diagnostic reagents, but also affect almost all performance indicators of the reagents, thereby causing the reagents to fail.
[0003] Preservatives are chemical substances that can interfere with the growth, reproduction and other life activities of microorganisms such as bacteria and fungi. There are three main antibacterial principles of preservatives. The first is to disrupt the metabolism of normal biological enzyme systems and interfere with their synthesis, thereby reducing their activity; the second is to destroy the protein substances involved in the basic life activities of microorganisms, causing the proteins to coagulate and denature, losing the most basic material conditions for maintaining life activities, and then interfering with or even completely destroying the growth and reproduction of microorganisms; the third is to destroy the permeability of microbial cell membranes, interfere with the elimination of their enzymes and metabolites, causing them to be unable to continue their life activities and die.
[0004] The most widely used preservatives in the field of in vitro diagnostics are azides and organic mercury. Sodium azide is a typical representative of azides. Because azides contain amino groups, they can inhibit the activity of multiple enzymes of microorganisms and can cause abnormal cell phosphorylation and cell respiration. However, because they can block the electron transport chain of living cells, they are highly toxic to almost all organisms, including humans, and pose a serious threat to the environment. Organic mercury antibacterial agents can react with sulfhydryl groups in microorganisms, inactivate enzymes, and destroy respiratory metabolism, but they are usually also very toxic and have a relatively serious residual toxicity problem, which is also a serious environmental pollution. Summary of the invention
[0005] The present invention provides a preservative for in vitro diagnostic reagents and its application, so as to solve the problem that the preservatives in the prior art are toxic and inhibit the tool enzymes in the diagnostic reagents, resulting in reduced activities of the tool enzymes, antibodies, etc., and further leading to reduced measurement precision of the diagnostic reagents.
[0006] The present application provides a preservative for in vitro diagnostic reagents, comprising: a composition of a diethyl acetamidomalonate solution, a dilauryl glycerol sulfate solution and diethyltriaminepentaacetic acid, wherein the molar ratio of the diethyl acetamidomalonate in the diethyl acetamidomalonate solution and the dilauryl glycerol sulfate in the dilauryl glycerol sulfate solution to the diethyltriaminepentaacetic acid is 1:(0.4-20):(0.5-5).
[0007] Furthermore, the molar ratio of diethyl acetamidomalonate in the diethyl acetamidomalonate solution to dilauryl glycerol sulfate in the dilauryl glycerol sulfate solution is 1:(1-8):(0.75-2).
[0008] Further, the diethyl acetamidomalonate solution is prepared by the following method:
[0009] Diethyl acetamidomalonate was weighed according to the formula amount, and the diethyl acetamidomalonate was dissolved in a polar organic solvent to prepare a diethyl acetamidomalonate solution with a concentration of 1 mM.
[0010] Furthermore, the dilauryl glycerol sulfate solution is prepared by the following method:
[0011] Dilaurin sulfate was weighed according to the formula, and the dilaurin sulfate was dissolved in a polar organic solvent to prepare a dilaurin sulfate solution with a concentration of 1 mM.
[0012] In order to solve the above technical problems, an embodiment of the present application further provides a creatine kinase (CK) assay reagent, comprising the preservative for in vitro diagnostic reagents as described above.
[0013] In order to solve the above technical problems, an embodiment of the present application further provides a urea (UREA) assay reagent, comprising the preservative for in vitro diagnostic reagents as described above.
[0014] In order to solve the above technical problems, the embodiments of the present application also provide a γ-glutamyl transferase (GGT) assay reagent, comprising the preservative for in vitro diagnostic reagents as described above.
[0015] Compared with the prior art, the embodiments of the present application have the following beneficial effects:
[0016] The preservative for in vitro diagnostic reagents provided in the present application is almost non-toxic, only inhibits the metabolic process of bacteria, has strong antibacterial ability, improves the stability of the reagent, and does not inhibit the compatibility of the tool enzyme, does not affect the reaction of the reagent, and can be widely used. DETAILED DESCRIPTION
[0017] The technical solutions in the embodiments of the present invention are described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0018] An embodiment of the present application provides a preservative for in vitro diagnostic reagents, including a composition of diethyl acetamidomalonate solution, dilauryl glycerol sulfate solution and diethyltriaminepentaacetic acid, wherein the molar ratio of diethyl acetamidomalonate in the diethyl acetamidomalonate solution, dilauryl glycerol sulfate in the dilauryl glycerol sulfate solution and diethyltriaminepentaacetic acid is 1:(0.4-20):(0.5-5), and the molar ratio can preferably be 1:(1-8):(0.75-2).
[0019] Diethyl acetamidomalonate, dilauryl glycerol sulfate and diethyltriamine pentaacetic acid are three new, stable and low-cost preservatives; diethyl acetamidomalonate can inhibit the activity of multiple enzymes of microorganisms due to its structural formula containing amino groups, and can cause abnormal cell phosphorylation and cell respiration, so it can play a good antibacterial role. Dilauryl glycerol sulfate destroys the permeability of microbial cell membranes, interferes with the elimination of its enzymes and metabolites, and causes it to be unable to continue its life activities. Diethyltriamine pentaacetic acid can complex fungi and other microorganisms with trace element ions required for life activities, but has no effect on most of the ion substances in the reagent, and basically has no interference with the performance of the reagent. The preservative composition for in vitro diagnostic reagents of the present application combines the performance of the three preservatives, and has better preservative performance than when the three preservatives are used alone. The three preservatives have a synergistic preservative effect, which can improve the preservative performance.
[0020] In this embodiment, acetamidomalonate diethyl ester and dilauryl glycerol sulfate are weighed according to the weight given in the formula, acetamidomalonate diethyl ester is dissolved in a polar organic solvent to obtain acetamidomalonate diethyl ester solution (liquid A), and dilauryl glycerol sulfate is dissolved in a polar organic solvent to obtain dilauryl glycerol sulfate solution (liquid B), and the final concentration of each of the two is 1 mM. Among them, the components of the polar organic solvent include: dimethyl sulfoxide, ethanol, methanol, etc.
[0021] The diethyl acetamidomalonate solution and the dilauryl glycerol sulfate solution are used as stock solutions. When the diethyl acetamidomalonate solution and the dilauryl glycerol sulfate solution are used as preservatives for in vitro diagnostic reagents, the two stock solutions are diluted and mixed to a predetermined concentration before use.
[0022] The stock solution was diluted and mixed in the IVD reagent to the predetermined concentration for use in the following experiments.
[0023] Example 1
[0024] Prepare the creatine kinase (CK) assay reagent according to the components and concentrations in Table 1 below.
[0025] Table 1
[0026]
[0027] In this embodiment, the in vitro diagnostic reagent is a creatine kinase (CK) assay reagent, which is a double reagent consisting of a first type reagent R1 and a second type reagent R2. The double reagents are stored separately. When used, the first type reagent R1 and the second type reagent R2 are mixed to prepare the CK assay reagent.
[0028] The components of the CK assay reagent include imidazole buffer, glucose, ethylenediaminetetraacetic acid, hexokinase, adenosine diphosphate, adenosine monophosphate, N-acetylcysteine, oxidative coenzyme II and 6-phosphate glucose dehydrogenase. The above components are added to purified water according to the concentrations in Table 1, mixed and stirred, and the pH value is adjusted.
[0029] Among them, the preservative is added to the CK assay reagent using the above-mentioned acetamidomalonate diethyl ester solution, dilauryl glycerol sulfate solution and diethyltriamine pentaacetic acid. Both the acetamidomalonate diethyl ester solution and the dilauryl glycerol sulfate solution use dimethyl sulfoxide as an organic solvent. Two groups of CK assay reagents are set up as a control group, and the first group of CK reagents is added with a combination of acetamidomalonate diethyl ester solution, dilauryl glycerol sulfate solution and diethyltriamine pentaacetic acid (i.e., the first group adds a preservative), and the second group of CK reagents is not added with any preservative.
[0030] In this embodiment, in the first group of CK reagents, the final concentration of diethyl acetamidomalonate is 10 μM, the final concentration of dilauryl sulfate is 20 μM, and the final concentration of diethyltriamine pentaacetic acid is 15 μM. Reagent measurement parameters: temperature: 37°C, detection main wavelength 340nm, secondary wavelength 405nm, 10 μL sample, add 200 μL R1 and mix, incubate at 37°C for 5 minutes, add 50 μL R2 and mix, delay for 3 minutes, continuously monitor the absorbance change rate for 1 to 3 minutes at the measurement wavelength, and calculate CK activity (U / L) = (△A / min measurement ÷ △A / min standard) × C standard.
[0031] According to the above measurement settings, the measurement was performed on the Hitachi 7100 fully automatic biochemical analyzer, and the △A / min values of 10 clinical samples were recorded. The results are shown in Table 2:
[0032] Table 2 Creatine kinase (CK) assay reagent CK activity
[0033]
[0034] The results in the table show that there is no significant difference in the CK activity value of the samples with and without the addition of the preservative of the present application, indicating that the preservative of the present application does not affect the reagent reaction.
[0035] Example 2
[0036] Prepare urea assay reagent according to the components and concentrations in Table 3 below.
[0037] Table 3
[0038]
[0039]
[0040] In this embodiment, the in vitro diagnostic reagent is a urea (Urea) assay reagent, which is a double reagent consisting of a first type reagent R1 and a second type reagent R2. The double reagents are stored separately. When used, the first type reagent R1 and the second type reagent R2 are mixed to prepare the Urea assay reagent.
[0041] Wherein, the preservative is added to the Urea assay reagent using the above-mentioned acetamidomalonate diethyl ester solution, dilauryl glycerol sulfate solution and diethyltriamine pentaacetic acid. In the present embodiment, the acetamidomalonate diethyl ester solution and the dilauryl glycerol sulfate solution both use ethanol as an organic solvent. Two groups of Urea assay reagents are set as a control group, and a composition of acetamidomalonate diethyl ester solution, dilauryl glycerol sulfate solution and diethyltriamine pentaacetic acid is added to the first group of Urea reagents (i.e., the first group adds a preservative), and no preservative is added to the second group of Urea reagents.
[0042] In this embodiment, in the first group of Urea reagents, the final concentration of diethyl acetamidomalonate is 15 μM, the final concentration of dilauryl sulfate is 40 μM, and the final concentration of diethyltriamine pentaacetic acid is 18 μM. Reagent measurement parameters: temperature: 37°C, detection main wavelength 340nm, secondary wavelength 405nm, 5 μL sample, add 200 μL R1 and mix, incubate at 37°C for 5 minutes, add 50 μL R2 and mix, delay 1.5 minutes, continuously monitor the absorbance change rate for 3 minutes at the measurement wavelength, and calculate the Urea concentration (mmol / L) = (△A / min measurement ÷ △A / min standard) × C standard.
[0043] According to the above measurement settings, the measurement was performed on the Hitachi 7100 fully automatic biochemical analyzer, and the Urea concentration values of 10 clinical samples were recorded. The results are shown in Table 4:
[0044] Table 4
[0045]
[0046] The results in the table show that there is no significant difference in the Urea concentration values of the samples with and without the addition of the preservative of the present application, indicating that the preservative of the present application does not affect the reagent reaction.
[0047] Example 3
[0048] The γ-glutamyl transferase (GGT) assay reagent was prepared according to the components and concentrations in Table 5 below.
[0049] Table 5
[0050]
[0051] In this embodiment, the in vitro diagnostic reagent is a γ-glutamyl transferase (GGT) assay reagent, and the GGT assay reagent is a double reagent, which is a first type reagent R1 and a second type reagent R2. The double reagents are stored separately. When used, the first type reagent R1 and the second type reagent R2 are mixed to prepare the GGT assay reagent.
[0052] Among them, the preservative is added to the GGT assay reagent using the above-mentioned acetamidomalonate diethyl ester solution, dilauryl glycerol sulfate solution and diethyltriamine pentaacetic acid. In the present embodiment, acetamidomalonate diethyl ester solution and dilauryl glycerol sulfate solution both use methanol as an organic solvent. Two groups of GGT assay reagents are set as a control group, and a composition of acetamidomalonate diethyl ester solution, dilauryl glycerol sulfate solution and diethyltriamine pentaacetic acid is added to the first group of GGT reagents (i.e., the first group adds a preservative), and no preservative is added to the second group of GGT reagents.
[0053] In this embodiment, in the first group of GGT reagents, the final concentration of diethyl acetamidomalonate is 20 μM, the final concentration of dilauryl sulfate is 60 μM, and the final concentration of diethyltriamine pentaacetic acid is 20 μM. Reagent measurement parameters: temperature: 37°C, detection main wavelength 340nm, secondary wavelength 405nm, 12.5 μL sample, add 200 μL R1 and mix, incubate at 37°C for 5 minutes, add 50 μL R2 and mix, delay for 1 minute, continuously monitor the absorbance change rate for 1 to 3 minutes at the measurement wavelength, and calculate GGT activity (U / L) = (△A / min measurement ÷ △A / min standard) × C standard.
[0054] According to the above measurement settings, the measurement was performed on the Hitachi 7100 fully automatic biochemical analyzer, and the GGT activity values of 10 clinical samples were recorded. The results are shown in Table 6:
[0055] Table 6
[0056]
[0057]
[0058] The results in the table show that there is no significant difference in the GGT activity value of the samples with and without the addition of the preservative of the present application, indicating that the preservative of the present application does not affect the reagent reaction.
[0059] Example 4
[0060] Prepare the reagents according to the components and concentrations in Table 7 below, as shown in Table 7:
[0061] Table 7
[0062]
[0063] In this embodiment, the reagents are set to 3 groups, and the components of each group of reagents include disodium hydrogen phosphate, potassium chloride, sodium chloride and bovine serum albumin. The above components are added to purified water according to the concentrations in Table 7, mixed and stirred, and the pH value is adjusted. Different preservatives are added to the 3 groups of reagents, group A is not added, group B is added with 0.5g / L sodium azide as a preservative, and group C is added with a preservative containing 15μM diethyl acetamidomalonate, 40μM dilauryl sulfate and diethyltriamine pentaacetic acid with a final concentration of 18μM.
[0064] The three test reagents were stored in an incubator at 37°C for 4 weeks, and finally a bacterial confirmation test was performed on each test material after storage.
[0065] Bacteria confirmation test: Small samples of the three groups of reagents were scraped onto culture medium and placed in an incubator at 37°C for 1 to 5 weeks. The presence or absence of bacterial growth was visually confirmed. The results are shown in Table 8 below.
[0066] Table 8 Bacterial growth in different groups
[0067]
[0068] As shown in Table 8 above, bacteria grew within one week without adding preservatives (Group A), bacteria started to grow in the 5th week with sodium azide (Group B), and no bacterial proliferation was observed within 5 weeks with the addition of the preservative of the present application (Group C).
[0069] Example 5
[0070] Prepare the reagents according to the components and concentrations in Table 9 below, as shown in Table 9:
[0071] Table 9
[0072]
[0073] In this embodiment, the reagents are set into 24 groups, and the components of each group of reagents include disodium hydrogen phosphate, potassium chloride, sodium chloride and bovine serum albumin. The above components are added to purified water according to the concentrations in Table 9 and mixed evenly, the pH value is adjusted, and different amounts of diethyl acetamidomalonate, dilauryl sulfate and diethyltriamine pentaacetic acid are added to each group as preservatives.
[0074] The 27 test reagents were stored in an incubator at 37°C for 4 weeks, and finally a bacterial confirmation test was performed on each test material after storage.
[0075] Bacteria confirmation test: Small samples of each of the 24 groups of reagents were scraped onto culture medium and placed in an incubator at 37°C for 6 weeks. The presence or absence of bacterial growth at the end of the second and sixth weeks was visually confirmed. The results are shown in Table 10 below.
[0076] Table 10 Antibacterial effects of different concentrations of diethyl acetamidomalonate, dilauryl sulfate and diethyltriamine pentaacetic acid
[0077]
[0078]
[0079] In the above table, the addition amount of diethyl acetamidomalonate, dilauryl glycerol sulfate and diethyltriamine pentaacetic acid is the molar concentration of each component in the in vitro diagnostic reagent, and the ratio of the three concentrations is the molar ratio. From Table 10 above, it can be seen that the addition amount of diethyl acetamidomalonate, dilauryl glycerol sulfate and diethyltriamine pentaacetic acid is 1: (0.4-20): (0.5-5), and the antibacterial effect is better within 2 weeks.
[0080] Since diethyl acetamidomalonate contains an amino group in its structural formula, it can inhibit the activity of multiple enzymes of microorganisms and cause abnormal cell phosphorylation and cell respiration, so it can play a good antibacterial role. Dilaurin sulfate destroys the permeability of microbial cell membranes, interferes with the elimination of its enzymes and metabolites, and makes it unable to continue its life activities. Diethyltriamine pentaacetic acid can complex the trace element ions required by fungi and other microorganisms to maintain their life activities. However, they cannot exert their effectiveness independently in the process of exerting their antibacterial effect, because metal ions are all charged and there is a certain polarity between molecular substances. If the ratio between diethyl acetamidomalonate, dilauryl sulfate and diethyltriamine pentaacetic acid is too high or too low, the charge balance between the substances will be destroyed, and substances with the same charge will form a repulsive effect, resulting in the inability to form a complex. The three substances must be combined into a large molecular complex in a certain proportion. Only by cooperating and synergizing with each other can they more efficiently interfere with the life activities of bacteria. Therefore, if the concentrations of the three components are too high or too low, bacteria will grow in the reagent. The mixing ratio of the three substances 1:(1~8):(0.75~2) will form more and more stable large molecular antibacterial complexes than the mixing ratio of 1:(0.4~20):(0.5~5), so bacteria will not grow for six weeks or even longer.
[0081] The in vitro diagnostic preservative of the present application is a combination of three substances, namely, diethyl acetamidomalonate, dilauryl sulfate and diethyltriaminepentaacetic acid. It not only has a strong preservative effect as described above, but also is not highly toxic like thimerosal and sodium azide. The preservative reagent using the combination has excellent stability during storage.
[0082] The above are merely embodiments of the present invention and are not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention are included in the scope of the claims of the present invention to be approved.
Claims
1. A preservative for in vitro diagnostic reagents, characterized in that: include: A composition of a diethyl acetamidomalonate solution, a dilauryl glycerol sulfate solution and diethyltriaminepentaacetic acid, wherein the molar ratio of the diethyl acetamidomalonate in the diethyl acetamidomalonate solution to the dilauryl glycerol sulfate and diethyltriaminepentaacetic acid in the dilauryl glycerol sulfate solution is 1:(0.4-20):(0.5-5).
2. The preservative for in vitro diagnostic reagents according to claim 1, characterized in that: The molar ratio of diethyl acetamidomalonate in the diethyl acetamidomalonate solution, dilauryl glycerol sulfate in the dilauryl glycerol sulfate solution and diethyltriaminepentaacetic acid is 1:(1-8):(0.75-2).
3. The preservative for in vitro diagnostic reagents according to claim 1, characterized in that: The diethyl acetamidomalonate solution is prepared by the following method: diethyl acetamidomalonate is weighed according to the formula amount, and the diethyl acetamidomalonate is dissolved in a polar organic solvent to prepare the diethyl acetamidomalonate solution with a concentration of 1 mM.
4. The preservative for in vitro diagnostic reagents according to claim 1, characterized in that: The dilaurin sulfate solution is prepared by the following method: dilaurin sulfate is weighed according to the formula, and the dilaurin sulfate is dissolved in a polar organic solvent to prepare the dilaurin sulfate solution with a concentration of 1 mM.
5. The preservative for in vitro diagnostic reagents according to claim 3 or 4, characterized in that: The polar organic solvent is one of dimethyl sulfoxide, ethanol and methanol.
6. A creatine kinase (CK) assay reagent, characterized in that: The invention comprises the preservative for in vitro diagnostic reagent according to any one of claims 1 to 5.
7. A urea (UREA) assay reagent, characterized in that: The invention comprises the preservative for in vitro diagnostic reagent according to any one of claims 1 to 5.
8. A reagent for measuring γ-glutamyl transferase (GGT), characterized in that: The invention comprises the preservative for in vitro diagnostic reagent according to any one of claims 1 to 5.
